全文获取类型
收费全文 | 1807篇 |
免费 | 222篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 35篇 |
妇产科学 | 40篇 |
基础医学 | 241篇 |
口腔科学 | 24篇 |
临床医学 | 220篇 |
内科学 | 396篇 |
皮肤病学 | 37篇 |
神经病学 | 123篇 |
特种医学 | 23篇 |
外科学 | 366篇 |
综合类 | 42篇 |
一般理论 | 4篇 |
预防医学 | 195篇 |
眼科学 | 13篇 |
药学 | 104篇 |
中国医学 | 1篇 |
肿瘤学 | 158篇 |
出版年
2023年 | 33篇 |
2022年 | 43篇 |
2021年 | 84篇 |
2020年 | 50篇 |
2019年 | 57篇 |
2018年 | 75篇 |
2017年 | 41篇 |
2016年 | 41篇 |
2015年 | 37篇 |
2014年 | 54篇 |
2013年 | 73篇 |
2012年 | 108篇 |
2011年 | 102篇 |
2010年 | 43篇 |
2009年 | 56篇 |
2008年 | 76篇 |
2007年 | 86篇 |
2006年 | 76篇 |
2005年 | 98篇 |
2004年 | 100篇 |
2003年 | 88篇 |
2002年 | 97篇 |
2001年 | 16篇 |
2000年 | 16篇 |
1999年 | 25篇 |
1998年 | 13篇 |
1997年 | 14篇 |
1996年 | 18篇 |
1995年 | 15篇 |
1994年 | 16篇 |
1993年 | 12篇 |
1992年 | 10篇 |
1991年 | 13篇 |
1990年 | 18篇 |
1989年 | 6篇 |
1988年 | 7篇 |
1987年 | 8篇 |
1986年 | 9篇 |
1984年 | 20篇 |
1983年 | 12篇 |
1982年 | 11篇 |
1981年 | 24篇 |
1980年 | 17篇 |
1979年 | 17篇 |
1978年 | 11篇 |
1977年 | 17篇 |
1976年 | 13篇 |
1975年 | 10篇 |
1931年 | 6篇 |
1927年 | 8篇 |
排序方式: 共有2039条查询结果,搜索用时 31 毫秒
81.
Buschke-Ollendorff syndrome 总被引:1,自引:0,他引:1
Kim GH Dy LC Caldemeyer KS Mirowski GW 《Journal of the American Academy of Dermatology》2003,48(4):600-601
82.
Social and behavioural factors associated with condom use among direct sex workers in Siem Reap,Cambodia
下载免费PDF全文
![点击此处可从《Sexually transmitted infections》网站下载免费的PDF全文](/ch/ext_images/free.gif)
OBJECTIVES: To determine the social and behavioural factors associated with condom use among direct sex workers in Siem Reap, Cambodia. METHODS: Using a structured behavioural questionnaire, interviews were conducted with 140 direct sex workers attending a health centre in Siem Reap for HIV screening. RESULTS: Consistent condom use with their clients was reported by 78% of sex workers compared to only 20% with their non-paying partners. Consistent condom use with clients was significantly higher among higher income than lower income sex workers (adjusted prevalence ratio: 1.91, 95% CI: 1.15 to 3.18) and those with good rather than poor negotiation skills (adjusted prevalence ratio: 1.51, 95% CI: 1.01 to 2.26), after adjustment for age, educational level, marital status, number of sexual encounters per week, and knowledge of AIDS/HIV and sexually transmitted infections. The most frequently reported reason for not using condoms with clients was not being able to persuade them (66.7%), while for non-paying partners, the reason was that they loved them (60.0%). CONCLUSION: To complement the government's current programme of client education, 100% condom policy and brothel administrative measures, additional strategies to increase condom use among clients and non-paying partners should be directed at (i) the social policy and community levels to address sex workers' economic and cultural barriers to condom use, and (ii) personal level empowerment through developing sex workers' condom negotiation skills. 相似文献
83.
Raja S Luketich JD Kelly LA Gooding WE Finkelstein SD Godfrey TE 《The Journal of thoracic and cardiovascular surgery》2002,123(3):475-82; discussion 482-3
84.
Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence 总被引:3,自引:0,他引:3
Dmochowski RR Davila GW Zinner NR Gittelman MC Saltzstein DR Lyttle S Sanders SW;Transdermal Oxybutynin Study Group 《The Journal of urology》2002,168(2):580-586
PURPOSE: We evaluated the efficacy and safety of an oxybutynin transdermal delivery system (TDS) in a general population of patients with overactive bladder and urge or mixed urinary incontinence. MATERIALS AND METHODS: Following symptom stabilization or treatment withdrawal 520 adult patients were randomized to 12 weeks of double-blind daily treatment with 1.3, 2.6 or 3.9 mg. oxybutynin TDS or placebo administered twice weekly, followed by a 12-week open-label, dose titration period to assess efficacy and safety further. Evaluations included patient urinary diaries, incontinence specific quality of life and safety. RESULTS: A dose of 3.9 mg. daily oxybutynin TDS significantly reduced the number of weekly incontinence episodes (median change -19.0 versus -14.5, p = 0.0165), reduced average daily urinary frequency (mean change -2.3 versus -1.7, p = 0.0457), increased average voided volume (median change 24 versus 6 ml., p = 0.0063) and significantly improved quality of life (Incontinence Impact Questionnaire total score, p = 0.0327) compared with placebo. Average voided volume increased in the daily 2.6 mg. group (19 ml., p = 0.0157) but there were no other significant differences between 1.3 and 2.6 mg. oxybutynin TDS and placebo. The most common adverse event was application site pruritus (oxybutynin TDS 10.8% to 16.8%, placebo 6.1%). Dry mouth incidence was similar in both groups (7.0% versus 8.3%, p not significant). In the open-label period a sustained reduction of nearly 3 incontinence episodes per day was reported for all groups. CONCLUSIONS: Doses of 2.6 and 3.9 mg. oxybutynin TDS daily improve overactive bladder symptoms and quality of life, and are well tolerated. Transdermal oxybutynin is an innovative new treatment for overactive bladder. 相似文献
85.
Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy 总被引:14,自引:0,他引:14
Randhawa PS Vats A Zygmunt D Swalsky P Scantlebury V Shapiro R Finkelstein S 《Transplantation》2002,74(4):485-488
BACKGROUND: BK virus (BKV) allograft nephropathy (BKVAN) is a complication in renal transplantation recipients. Histopathology is the gold standard for diagnosis. Quantitative polymerase chain reaction (PCR) assay for renal biopsy has not been evaluated as a diagnostic test. Determination of renal BKV load may identify patients at risk for disease before histologic nephropathy. METHODS: Quantitative PCR assay for BKV DNA was performed in 28 biopsies of patients with BKVAN; 50 biopsies were performed before a diagnosis of BKVAN, and 126 control biopsies were from patients without a history of BKVAN. RESULTS: BKV DNA was present in 19 of 50 (38%) biopsies performed 1 to 164 weeks before diagnosis of BKVAN. The viral load (mean 216 copies/cell) was lower than in biopsies of patients with BKVAN (mean 6063 viral copies/cell, <0.05). In 10 of 127 (7.8%) control biopsies, a low level of BKV DNA (mean 3.8 copies/cell) was found in three biopsies from chronic allograft nephropathy patients; two biopsies with acute rejection; four biopsies with borderline change; and one biopsy with cytomegalovirus nephritis. CONCLUSION: BKV load exceeding 59 copies per cell identified all cases of BKVAN. The diagnostic sensitivity, specificity, positive predictive value, and negative predictive value of quantitative PCR were 100%, 92.1%, 73.6%, and 100%, respectively. Lower levels of BKV DNA were identified in biopsies performed before viral nephropathy development. Future research will determine if earlier recognition of at-risk patients allows application of antiviral strategies to improve graft outcome. 相似文献
86.
87.
88.
Farnesyltransferase inhibitors (FTIs) belong to a group of agents originally designed to prevent membrane attachment of Ras protein by inhibiting a key step in its post-translational processing. It was thus hypothesized that FTIs would curtail the oncogenic ras-mediated proliferative and antiapoptotic signals that are activated in human tumors. Although the Ras protein is mutated in only < 5% of breast cancers, there are multiple aberrant pathways that lead to activation of wild-type ras signaling. Moreover, FTIs have consistently demonstrated efficacy in tumors regardless of their ras mutational status. Thus, the role of other protein targets in mediating the antitumor effect of FTIs is being elucidated. This article reviews current data on the use of FTIs in breast cancer. 相似文献
89.
Lai KN Chan LY Tang SC Tsang AW Guo H Tse KC Yip T Leung JC 《Journal of the American Society of Nephrology : JASN》2002,13(9):2309-2319
IgA nephropathy (IgAN) is characterized by predominant mesangial polymeric IgA1 (pIgA1) deposits, with increased plasma IgA1 levels. Plasma IgA levels are determined by the rate of IgA production, uptake by leukocytes, and removal by hepatocytes. Fc(alpha) receptor 1 (Fc(alpha)R1) is a candidate molecule for the regulation of IgA levels, but reports of its expression in leukocytes in IgAN are conflicting. Increased binding of endogenous IgA to circulating granulocytes and monocytes in IgAN was demonstrated in this study. Fc(alpha)R1 expression on leukocytes was increased, independently of plasma IgA levels. Fc(alpha)R1 was not saturated in leukocytes, because of internalization of IgA after uptake. Further binding of exogenous IgA isolated from individual subjects was observed with leukocytes from the same subjects. Compared with cells from control subjects, granulocytes but not monocytes from patients with IgAN exhibited a greater binding capacity for exogenous IgA, predominantly pIgA. To circumvent the possibility that endogenous IgA might alter Fc(alpha)R1 expression, granulocytes or monocytes derived from the HL-60 or U937 cell lines were used to explore the nature of IgA binding. A higher affinity for pIgA was demonstrated. Inhibition studies using unlabeled IgA, other serum proteins, or a specific Fc(alpha)R1-blocking antibody suggested binding mechanisms other than Fc(alpha)R1 for pIgA uptake by leukocytes. This study also suggested the migration and/or sequestration of "activated" leukocytes with predominant lambda-IgA in the mononuclear phagocytic system or inflammatory tissues, after the initial binding of lambda-pIgA. These immunologic abnormalities might contribute to the glomerulointerstitial injury in IgAN, in the presence of leukocytic infiltration. 相似文献
90.
The complement system is being increasingly implicated in the pathogenesis of progressive renal disease resulting from persistent proteinuria. It has recently been established that renal tubular cells can produce complement, activate complement, and respond to complement activation. Complement proteins that pass through the glomerular barrier along with other serum proteins in the proteinuric state may become activated at the tubular epithelial brush border, and lead to a cascade of events culminating in cell injury. Furthermore, nephrotic components in the urinary space may cause direct activation of the tubular cells to overexpress complement and contribute to local tissue injury. In this review, we will discuss the current evidence supporting a role for complement in the pathogenesis of progressive tubulointerstitial damage in the proteinuric state. The possibility of complement inhibition intervening in progressive tubulointerstitial injury due to proteinuric glomerular disease will also be considered. 相似文献